These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29726577)

  • 21. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects.
    Riva M; Nitert MD; Voss U; Sathanoori R; Lindqvist A; Ling C; Wierup N
    Cell Tissue Res; 2011 Dec; 346(3):393-405. PubMed ID: 22108805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blocking TLR4-NF-κB pathway protects mouse islets from the combinatorial impact of high fat and fetuin-A mediated dysfunction and restores ability for insulin secretion.
    Mukhuty A; Fouzder C; Kundu R
    Mol Cell Endocrinol; 2021 Jul; 532():111314. PubMed ID: 33989718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells.
    Kim MJ; Choi OK; Chae KS; Lee H; Chung SS; Ham DS; Kim JW; Yoon KH; Park KS; Jung HS
    Islets; 2015; 7(5):e1129096. PubMed ID: 26744903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta cell specific probing with fluorescent exendin-4 is progressively reduced in type 2 diabetic mouse models.
    Lehtonen J; Schäffer L; Rasch MG; Hecksher-Sørensen J; Ahnfelt-Rønne J
    Islets; 2015; 7(6):e1137415. PubMed ID: 26963143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein.
    Farris W; Mansourian S; Leissring MA; Eckman EA; Bertram L; Eckman CB; Tanzi RE; Selkoe DJ
    Am J Pathol; 2004 Apr; 164(4):1425-34. PubMed ID: 15039230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MC1568 improves insulin secretion in islets from type 2 diabetes patients and rescues β-cell dysfunction caused by Hdac7 upregulation.
    Daneshpajooh M; Eliasson L; Bacos K; Ling C
    Acta Diabetol; 2018 Dec; 55(12):1231-1235. PubMed ID: 30088095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DGAT1 inhibitors protect pancreatic β-cells from palmitic acid-induced apoptosis.
    Huang JS; Guo BB; Wang GH; Zeng LM; Hu YH; Wang T; Wang HY
    Acta Pharmacol Sin; 2021 Feb; 42(2):264-271. PubMed ID: 32737468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.
    Yuan T; Rafizadeh S; Gorrepati KD; Lupse B; Oberholzer J; Maedler K; Ardestani A
    Diabetologia; 2017 Apr; 60(4):668-678. PubMed ID: 28004151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes.
    Yoshida S; Tanaka H; Oshima H; Yamazaki T; Yonetoku Y; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Oct; 400(4):745-51. PubMed ID: 20816753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.
    Mu J; Woods J; Zhou YP; Roy RS; Li Z; Zycband E; Feng Y; Zhu L; Li C; Howard AD; Moller DE; Thornberry NA; Zhang BB
    Diabetes; 2006 Jun; 55(6):1695-704. PubMed ID: 16731832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
    Ishibashi K; Hara A; Fujitani Y; Uchida T; Komiya K; Tamaki M; Abe H; Ogihara T; Kanazawa A; Kawamori R; Watada H
    Biochem Biophys Res Commun; 2013 Nov; 440(4):570-5. PubMed ID: 24103756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinctions between the islets of mice and men: implications for new therapies for type 1 and 2 diabetes.
    Levetan CS; Pierce SM
    Endocr Pract; 2013; 19(2):301-12. PubMed ID: 23186955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial Effects of Small Molecule Oligopeptides Isolated from Panax ginseng Meyer on Pancreatic Beta-Cell Dysfunction and Death in Diabetic Rats.
    Xu M; Sun B; Li D; Mao R; Li H; Li Y; Wang J
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28954411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
    Kaya-Dagistanli F; Ozturk M
    Acta Histochem; 2013 Jul; 115(6):577-86. PubMed ID: 23351716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice.
    Wei X; Ke B; Zhao Z; Ye X; Gao Z; Ye J
    PLoS One; 2014; 9(4):e95399. PubMed ID: 24740421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
    Whalley NM; Pritchard LE; Smith DM; White A
    J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elovl6 Deficiency Improves Glycemic Control in Diabetic
    Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
    Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liraglutide Activates AMPK Signaling and Partially Restores Normal Circadian Rhythm and Insulin Secretion in Pancreatic Islets in Diabetic Mice.
    Wang K; Sun Y; Lin P; Song J; Zhao R; Li W; Hou X; Wang C; Wang L; Zhu P; Chen L
    Biol Pharm Bull; 2015; 38(8):1142-9. PubMed ID: 26040899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.